Controlled & Modified Drug Release Summit 2023: The Next Generation of Drug and Therapeutic Delivery is Here (Princeton, NJ, United States – May 16-17, 2023) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “2023 Controlled & Modified Drug Release Summit” conference has been added to ResearchAndMarkets.com’s offering.

The next generation of drug and therapeutic delivery is here.

Attend and connect with 160+ senior drug development innovators this May and uncover the industry’s latest formulation and delivery technologies for improving drug product performance and developing next-gen products.

Uncover a multitude of new product development strategies, formulation approaches, and delivery technologies in just 2 days. Likewise, access all session content for your team post-Summit via our on-demand portal. Benefit from 30+ expert sessions and panels including:

• Targeted and Modified Delivery of Molecules: A Patient-Centric Journey
• Nucleic Acid Delivery for Enabling MRNA: Enabling the Next Generation of Therapeutics
• Using Modeling to Design Better Sustained Release Formulations
• Challenges Associated with Melt-Extruded Controlled Release Dosage Forms
• Optimizing Formulation Development for Oral Modified Release Drug Products
• Achieving a Sustained Release Profile in Drug Discovery
• Exploring Opportunities for Sustained Release Long-Acting Injectables:
• MED 3D Printing for Oral Modified Release Products
• Advances in Ocular Delivery: Examining Multiple Drug Modalities and Pre-Clinical Models
• Overcoming Bioavailability Challenges of Peptide-Based Drug Product Development

2022’s Speakers Included:

Pratik Saha, PhD

Director, Biopharmaceutics, Pharmaceutical Development

GlaxoSmithKline

Dipen Desai, PhD

Vice President, Complex Product Development

Amneal

Arijit Chakravarty, PhD

Chief Executive Officer

Fractal Therapeutics

Arul Joseph, PhD

Senior Director, CMC Pharmaceutical Dev

Otsuka Pharmaceuticals

Ramesh Palaparthy, PhD

Executive Director, Clinical Pharmacology

Gilead Sciences

Mikhail Murashov, PhD

Senior Scientist, Preclinical Development

Merck & Co.

Gillie Roth, PhD

Scientist, Preclinical & Translational PKPD

Genentech

Ingrid Liu, PhD

Senior Scientist, Oral Formulation Sciences

Merck & Co.

Wenzhan Yang, PhD

Senior Scientist, Pharmaceutical Development

AstraZeneca

Debanjan Das, PhD

Senior Associate Director & Science Fellow

Bayer

Hamsini Dhoolypala, PhD

Senior Associate Scientist, Pharmacokinetics

Amgen

Xiaoling Li, PhD

Co-Founder & CEO

Triasek

Iriny Ekladious, PhD

Associate Principal Scientist, Sterile and Specialty Products

Merck & Co.

Santipharp Panmai, PhD

Vice President and Head of Early-phase Formulation Development

WuXi STA

Nitin Swarnakar, PhD

North American Pharma Applications Manage

BASF

For more information about this conference visit https://www.researchandmarkets.com/r/tg4vn

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900